๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The SORL1 polymorphism rs985421 may confer the risk for amnestic mild cognitive impairment and Alzheimer's disease in the Han Chinese population

โœ Scribed by Jin, Chunhui; Zhang, Lili; Xian, Yiping; Liu, Xiaowei; Wu, Yue; Zhang, Feng; Zhu, Jianzhong; Zhang, Guofu; Chen, Caixia; Gong, Ronglan; Zhang, Lingyun; Yuan, Jianmin; Zhang, Fuquan; Tian, Lin; Wang, Guoqiang; Cheng, Zaohuo


Book ID
121801784
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
672 KB
Volume
563
Category
Article
ISSN
0304-3940

No coin nor oath required. For personal study only.

โœฆ Synopsis


Although the pathogenetic mechanisms driving Alzheimer's disease (AD) are unclear, genetic variations may play an important role. Previous studies have identified that single nucleotide polymorphisms (SNPs) in the sortilin-related receptor, L (DLR class) A repeats containing (SORL1) gene are associated with AD or amnestic mild cognitive impairment (aMCI) patients. However, the association of SORL1 variants with AD or aMCI susceptibility in the Han Chinese population has not been adequately reported. Thus, we conducted a case-control study in 106 sporadic AD patients, 67 aMCI patients, and 179 healthy control Han Chinese subjects to determine whether SORL1 genetic variations alter the risk for AD or aMCI. Using the LDR-PCR method to genotype five polymorphisms in SORL1, we found significant associations (for AD: OR=1.968, 95% CI=1.273-3.042; for aMCI: OR=2.210, 95% CI=1.353-3.610) between the 'A' allele of the SORL1 SNP rs985421 and AD and aMCI, which may represent an ApoE ษ›4-independent risk factor for SAD. These findings suggest that the SORL1 SNP rs985421 may alter the risk for sporadic AD and aMCI in the Han Chinese population.


๐Ÿ“œ SIMILAR VOLUMES


Screening for amnestic mild cognitive im
โœ L. Rami; J. L. Molinuevo; R. Sanchez-Valle; B. Bosch; A. Villar ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 1 views

## Abstract ## Objectives To design and validate a new screening test for amnestic Mild Cognitive Impairment (Aโ€MCI) and early stage Alzheimer's disease (AD). ## Methods We develop a verbal episodic and semantic memory test: the Memory Alteration Test (M@T). Discriminative validity was assessed